NCT05752032View on ClinicalTrials.gov

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

Enrolling by invitationOBSERVATIONAL

Enrollment

16

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Osteoarthritis, Knee

Interventions

GENETIC

ICM-203

Long term follow-up

DRUG

Placebo

Long term follow-up

Trial Locations (2)

3220

Barwon Health, Geelong

5000

Royal Adelaide Hospital, Adelaide

All Listed Sponsors

lead

ICM Co. Ltd.

INDUSTRY